Omthera Pharmaceuticals Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale
Omthera Pharmaceuticals Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to AstraZeneca
DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Omthera Pharmaceuticals, Inc. ("Omthera") (NasdaqGM: OMTH) to AstraZeneca PLC for shareholders. Under the terms of the proposed sale, valued at approximately $323 million, Omthera shareholders will only receive $12.70 in cash for each share of Omthera stock owned, well below at least one analyst's estimate of $15.00 per share.
If you are an affected investor, and you want to learn more about the lawsuit or join the action, please contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 239-4568, via email at WBriscoe@TheBriscoeLawFirm.com or Zach Groover at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at firstname.lastname@example.org. There is no cost or fee to you.
The Omthera sale investigation centers on whether Omthera's shareholders are receiving adequate compensation for their shares in the proposed deal, whether the transaction undervalues Omthera's stock, and whether Omthera's board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. Notably, according to Yahoo! Finance, at least one analyst has estimated that the true inherent value of Omthera stock could be as high as $15.00 per share. Shareholder rights attorney Patrick Powers noted that "due in part to analyst estimates, the size of the deal, the lack of a significant premium and other factors, we believe this transaction may undervalue Omthera's stock. Our proposed lawsuit will seek to obtain the highest share price for all shareholders."
The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
Powers Taylor, LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.
KEYWORDS: United States North America Texas
The article Omthera Pharmaceuticals Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to AstraZeneca originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.